Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3085044 | Pediatric Neurology | 2013 | 10 Pages |
Abstract
Juvenile myasthenia gravis is an uncommon autoimmune disorder. Its management is not standardized. Juvenile myasthenia gravis is pathophysiologically similar to myasthenia gravis in adults. However, a number of significant particularities related to race, age at onset, severity, and antibody status complicate the management. We summarize the unique clinical features of juvenile myasthenia gravis and review the therapeutic options.
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
Cristian M. Ionita, Gyula Acsadi,